IDEAYA Biosciences, Inc. (IDYA) Return on equity 2019–2025
IDEAYA Biosciences, Inc. (IDYA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-11.1%FY2025 · since FY2019: -41.8% → -11.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -11.1% | +14.8 pp |
| FY2024 | -25.9% | -7.7 pp |
| FY2023 | -18.2% | -1.4 pp |
| FY2022 | -16.8% | -0.3 pp |
| FY2021 | -16.5% | +0.9 pp |
| FY2020 | -17.4% | +24.4 pp |
| FY2019 | -41.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More IDYA financial trends
IDYA RevenueIDYA Net incomeIDYA Net marginIDYA Gross profitIDYA Gross marginIDYA Operating incomeIDYA Operating marginIDYA Operating cash flowIDYA Free cash flowIDYA Capital expendituresIDYA Stock buybacksIDYA Dividends paidIDYA Total assetsIDYA Total liabilitiesIDYA Shareholders’ equityIDYA overview →